Trial NCT04128696

View at ClinicalTrials.gov 
Org. Study IDs: 209229
Secondary IDs: 2019-002263-99

Last trial update was posted on 2024-02-07

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma Carcinoma, Squamous Cell Head and Neck Neoplasms Squamous Cell Carcinoma of Head and Neck

Other Conditions

Neoplasms, Head and Neck

Stopping Reasons

The trial was stopped by the sponsor based on assessment of the clinical data

Limitations And Caveats

Data are reported following the interim analysis decision to stop further accrual into the study and discontinue feladilimab/placebo. The study primary completion analysis results should be interpreted with consideration of the immature data

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID